Margetuximab and Vinorelbine
About
Membership operator: AND
Therapies: 2
Therapies
Margetuximab (tx:ncit:C91733)
Vinorelbine (tx:ncit:C1275)
Therapeutic response
Precision oncology relationships for therapeutic response involving this therapy group.
Organizations
Biomarkers
Cancer types
Therapies
| Organizations | Biomarkers | Cancer types | Therapies | |
|---|---|---|---|---|
| FDA (2) | HER2-positive | Invasive Breast Carcinoma | Margetuximab, Vinorelbine |